---
category: news
title: "Enterprise Therapeutics Doses First Subjects in Phase 1 Trial for First-in-Class Cystic Fibrosis Therapy ETD002"
excerpt: "Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease,"
publishedDateTime: 2020-08-26T23:21:00Z
originalUrl: "https://www.lelezard.com/en/news-19380767.html"
webUrl: "https://www.lelezard.com/en/news-19380767.html"
type: article

provider:
  name: Le LÃ©zard
  domain: lelezard.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "PY4t7OjNtX/yJPxyEjHgya/hTsOfCVh+G9aIea9eHzOV7TJu+gGhVlMXnukQpCRVGAOQAJjTdWwPdWuw7qu2aPrr9oGxIovsQRDRPynyPzzUNOz/3VPdgOWrsxrZQNI7fewGi50xmawim34pQ4ujkvah3gcaZK9ToroPq7JBPZAarSKLmiMaUbnms0XO2N8A0oh+n8cJW7eMEgEWwjNvaOYRxfdYqTeDsnTzmW3UcwNiLkwhkmCovAmTEsIFTxvE/f8k5kiyIz5roKNVjk3iBknydq3SKx1Lq/Vd6gWDD3de+XGc6DvHS+RL80tP/8CN2kbjm2SO+bHBREVWlP30ef9zlJlqY1CZcCwSVYJrRas=;m/CGw9BU28Il6KT4LF8k8A=="
---

